NEW YORK (GenomeWeb News) – GeneThera today announced it has acquired a majority ownership of molecular diagnostic firm Applied Genetics for an undisclosed amount.
GeneThera said the deal is part of a broader strategy to begin revenue generation at Applied Genetics, which is based in Monterrey, Mexico and focuses on commercializing tests for Johne's disease in Mexico.
GeneThera is a molecular biotech firm based in Westminster, Colo. Its diagnostic solution, it said, is based on a genetic expression assay called GES and Johne's disease management system Herdcheck, which is "designed to function on a highly automated Fluorogenic PCR platform."
GES and Herdcheck are designed for a variety of diseases.
Johne's disease affects dairy cows, sheep, and goats and is caused by Mycobacterium Paratuberculosis sub. Avium (MAP). MAP has been shown in studies to be a cause of Crohn's disease in humans.